INS and metabolic syndrome: [19] that reported on other measures of glycemic control showed that in adults who were overweight or with obesity and with metabolic syndrome or conditions related to metabolic syndrome, there were reductions in fasting insulin, HOMA-IR, and HbA1c with WP compared with comparator interventions.